Psomagen, Inc.

₩2,670As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:950200Healthcare
Country South Korea
PE (Fwd) •••
TSR 6Y CAGR (25.20%)
Div yield —
ROE (10.39%)
Biological Products, Except Diagnostic Substances
Beta (5Y) (0.13)
PE TTM —
TSR TTM (21.70%)
Mkt cap ₩51.36B
ROIC (1.69%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩2,854
6.90%
20.51%
Hold 5|5|10|10|12
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
30.79
34.18
36.82
36.76
19.32%
29.28%
32.80%
29.79%
Revenue₩B
4.969
4.873
4.952
4.868
(1.39%)
(3.42%)
(3.27%)
(2.72%)
Peers (US$37.87M)
Cap (US$)
PE
37.84M
—
Capital
TTM
5Y
10Y
Leveragex
1.173
0.283
0.247
EBIT/Intx
3.945
0.245
0.233
Own earn%
28.10
(107.37)
(117.77)
Sh yield%
32.06
44.49
47.67
Owners
Insiders/Inst%
14.05
63.16
Short interest%
1.12
SBC / revenue%
5.27
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
21–28
$1 testx
—
Incr. ROIC%
14